Summary
Environmental stresses are increasingly acknowledged as core causes of abnormal neural induction leading to neural tube defects (NTDs). However, the mechanism responsible for environmental stress-triggered neural induction defects remains unknown. Here, we report that a spectrum of environmental stresses, including oxidative stress, starvation, and DNA damage, profoundly activate SIRT1, an NAD+-dependent lysine deacetylase. Both mouse embryos and in vitro differentiated embryonic stem cells (ESCs) demonstrated a negative correlation between the expression of SIRT1 and that of OCT6, a key neural fate inducer. Activated SIRT1 radically deacetylates OCT6, triggers an OCT6 ubiquitination/degradation cascade, and consequently increases the incidence of NTD-like phenotypes in mice or hinders neural induction in both human and mouse ESCs. Together, our results suggest that early exposure to environmental stresses results in the dysregulation of the SIRT1/OCT6 axis and increases the risk of NTDs.
Keywords: environmental stress, resveratrol, neural tube defects, neural induction, embryonic stem cell, Sirt1, Oct6
Graphical Abstract
Highlights
-
•
Environmental stresses profoundly activate SIRT1 during neural tube development
-
•
Activated SIRT1 deacetylates OCT6 and induces its ubiquitination/degradation
-
•
SIRT1/OCT6 axis is related to environmental stress-induced neural tube defects
-
•
SIRT1/OCT6 axis is involved in the early stage of normal neural tube development
In this article, Kang and colleagues demonstrate that environmental stresses profoundly activate SIRT1, which further deacetylates OCT6 and triggers an OCT6 ubiquitination/degradation cascade. Oct6, specifically expressed in the epiblast and early neuroectoderm, is indispensable for neural induction. Environmental stress-triggered dysregulation of the SIRT1/OCT6 axis leads to neural induction defects and neural tube defect-like phenotypes both in vivo and in vitro.
Introduction
Vertebrate embryonic development involves stepwise cell-fate conversion events. Neural induction is one of the most critical developmental events occurring during gastrulation, whereby a subset of epiblast cells acquires a neuroectodermal fate (Tam and Zhou, 1996). Neuroectodermal cells develop into all of the regional neural progenitors and ultimately the brain and spinal cord; thus, a failure of neural induction results in severe neural tube defects (NTDs) (Copp et al., 2003). Ninety percent of affected pregnancies will be terminated (Herrera-Araujo, 2016), with the survivors facing a risk of prenatal to postnatal lethality or lifelong disability, including neurological and cognitive complications. However, knowledge pertaining to abnormal neural induction in NTDs remains limited.
Previous studies have revealed that the suppression of bone morphogenetic protein (BMP) pathways and coordinated regulation of the fibroblast growth factor (FGF), transforming growth factor β, and calcineurin signaling pathways are central to the extrinsic control of neural induction (Cho et al., 2014, Liu et al., 2016a, Stavridis et al., 2007). These extracellular signals subsequently converge on specific lineage-determining transcription factors to regulate neural induction. For example, BMP/SMAD signaling suppresses commitment to the neural lineage via the induction of ID proteins (Ying et al., 2003a). The FGF-ERK1/2-PARP1 cascade directly activates Pax6 expression to advance human neuroectodermal specification (Yoo et al., 2011, Zhang et al., 2010). Various transcription factors have also been found to lead undifferentiated cells to adopt a neural fate intrinsically. The zinc-finger nuclear protein Zfp521 is required and sufficient to drive the intrinsic transition of embryonic stem cell (ESC) differentiation into neuroectodermal cells (Kamiya et al., 2011). The POU domain transcription factor Oct6 initiates internal neural induction programs by directly activating neural-lineage genes, such as Zfp521 and Pax6 (Zhu et al., 2014), when expressed in the epiblast and the early neuroectoderm during development (Zwart et al., 1996). Disruption of the hierarchies of these signaling or gene-regulatory networks during early embryonic development may underlie abnormal neural induction in NTDs. Although NTDs have long been proposed to be primarily triggered by external environmental stresses, the specific environmental sensors that function to translate these environmental stresses into intracellular gene-regulatory network activity during the neural induction stage remain largely unexplored.
Sirt1, a conserved NAD+-dependent lysine deacetylase, has been reported to be an environmental sensor that mediates intracellular responses to environmental states, such as redox state, nutrient availability, and DNA damage, in various organisms. In response to DNA damage or oxidative stress, Sirt1 is activated to repress p53-dependent apoptosis in mammalian cells (Luo et al., 2001), nuclear p53-mediated transactivation of proapoptotic genes in mouse cells (Han et al., 2008), and FOXO3-induced cell death in human cells (Brunet et al., 2004). Starvation-induced SIRT1 activation is required for the initiation of autophagy to cope with the lack of external nutrients in eukaryotes (Chang et al., 2015, Lee et al., 2008). Recently, Sirt1 was also found to be required to suppress neurogenesis or to induce oligodendrogenesis in neural stem/progenitor cells (Prozorovski et al., 2008, Stein and Imai, 2014), suggesting a profound role for Sirt1 during neural development.
Here, we report that environmental stresses activate SIRT1, which further deacetylates OCT6 and triggers an OCT6 ubiquitination/degradation cascade. Given that Oct6 is a crucial neural fate inducer during neural induction, environmental stress-triggered dysregulation of the SIRT1/OCT6 axis will therefore lead to neural induction defects and NTD-like phenotypes.
Results
Early Maternal Exposure to Resveratrol Induces NTD-like Phenotypes in Mouse Embryos
SIRT1 has long been thought to be activated by environmental stresses to promote the survival of adult cells (Chang et al., 2015, Kang et al., 2009). As a potent SIRT1 activator, resveratrol (RSV) has been used to reveal various noteworthy features of SIRT1 deacetylase activity during numerous biological processes, including neurodegeneration and senescence (Pallas et al., 2009, Wood et al., 2004). To mimic environmental stress-induced SIRT1 activation during early neural development, we subjected pregnant mice to daily intragastric administration of RSV (25 mg/kg/day) between gestational day 3.5 (GD3.5) and GD10.5. When euthanized at GD10.5, 37.1% of the embryos that were exposed to RSV treatment displayed clear neurological malformations, exhibiting either a smaller brain size or increased indentations between the prosencephalon/metencephalon or metencephalon/spinal cord (Figures 1A, 1D, S1A, and S1B). No obvious morphological changes related to the heart primordium or the limb buds were found. Histological analysis and staining for SOX1 and NESTIN showed that the entire neural tube was severely misshapen and the neurocoele became smaller; these phenotypes resembled NTDs (Figures 1B and 1C). Consistent with the NTD phenotype, the expression of NTD-risk genes (Gcn5, Folr1, Eya1, Six1, Alx1, Zic2, Acat2, etc.) also showed obvious downregulation in the RSV-treated embryos (Figures S1C and S1D), which is consistent with their lower expression pattern or loss-of-function mutations in other NTD models or NTD patients (Fairbridge et al., 2010, Harris and Juriloff, 2010, Hsieh et al., 2013). Moreover, the expression of typical neural-lineage genes (Sox1, Pax6, and N-cadherin) was lower in RSV-treated embryos (Figure 1E). Even when the dosage of RSV was reduced to 7.5 mg/kg/day, 25% of the embryos still exhibited NTD-like phenotypes (Figures 1A, 1D, and S1A). Increasing the dosage to 125 mg/kg/day increased the incidence of NTD-like phenotypes to 52.9% (Figures 1A, 1D, and S1A). Similar results were obtained when RSV was intraperitoneally injected at GD3.5 until GD10.5 (Figures S1E and S1F). These data suggest that SIRT1 activation plays a detrimental role in early embryonic neural tube development.
RSV Causes NTD-like Phenotypes in Teratomas
The teratoma formation assay is another in vivo system that mimics early embryonic development. We subcutaneously injected mouse ESCs (mESCs) into NOD/SCID mice, followed by daily intragastric administration of RSV. Teratomas formed within 3–4 weeks and were then harvested for histological and mRNA analysis. Histological analysis and SOX1 immunostaining showed that teratomas from the RSV-treated group presented minimal neural tube-like structures (Figures 1F and 1G). mRNA analysis also revealed that neural-lineage genes were expressed at lower levels (Figure 1H). In contrast, hallmark genes for pluripotency, endoderm, epidermis, and trophectoderm (Nanog, Gata4, Gata6, K18, K19, and Lamb1) were all upregulated (Figures 1I, S1G, and S1H). These results support a reduction of neural-lineage generation and a similar NTD-like phenotype in these RSV-treated teratomas.
RSV Hinders the Neural Induction of mESCs and Induced Epiblast Stem Cells In Vitro
To confirm the influence of SIRT1 activation on neural development, we selected a well-accepted system for the neural differentiation of mESCs in vitro involving serum-free cultured embryoid-body aggregates (SFEBs) (Watanabe et al., 2005). Using this system, mESCs were efficiently converted to a neural fate. This result was demonstrated by the sequential downregulation and activation of pluripotent genes, epiblast genes, neural-lineage genes, and neuronal genes during neural differentiation (Figure S2A). In addition, as 46C is a Sox1-GFP reporter line (Ying et al., 2003b), GFP expression faithfully recapitulated endogenous Sox1 expression and indicated a committed neural fate (Figures S2A–S2C). All of these observations suggest the usefulness of this in vitro differentiation system for mimicking dynamic neural developmental events.
When RSV was applied to neural differentiation medium, the generation of GFP+ neural-lineage cells was severely compromised in a dose-dependent manner (Figures 2A, 2B, and S2D). Immunostaining assays confirmed the reduced percentage of SOX1-GFP+/N-CADHERIN+ or SOX1+/NESTIN+ neural stem/progenitor cells generated in the RSV-treated group (Figures 2C, S2E, and S2F). qPCR analysis revealed that Sox1, Zfp521, Pax6, Nestin, and N-cadherin mRNA levels were all significantly reduced after RSV treatment (Figure 2D). We also confirmed that RSV treatment slightly affected the apoptosis or cell cycle of differentiated mESCs (Figures S2G and S2H). Additionally the mRNA levels of pluripotent genes (Nanog and Rex1), epiblast genes (Fgf5 and Dnmt3b), mesodermal genes (Mixl1 and Flk1), endodermal genes (Gata4 and Gata6), trophectodermal genes (Cdx2 and Lamb1), and epidermal genes (K18 and K19) were all increased after RSV treatment (Figure S2I). Similar results were obtained in another mESC line, R1 (Figures S2J and S2K). These data suggest that early exposure to SIRT1 activation preferentially hinders the neural-lineage specification of mESCs by maintaining mESCs in a pluripotent state or forcing the cells to adopt a non-neural fate in vitro.
To identify the SIRT1 activation-sensitive stage during neural differentiation, we applied RSV to differentiated mESCs at different time points until day 5, when the mESCs were mostly committed to neural progenitors under normal differentiation conditions. The most significant suppression of neural differentiation was achieved when RSV was added from day 0, 1 or 2, but not afterward (Figures S3A–S3C). Short-term RSV treatment from days 0–3 or days 2–3 also significantly inhibited neural differentiation (Figures S3D–S3F). These data suggest that differentiated mESCs are most sensitive to SIRT1 activation on days 2–3, defined as the neural induction period. Furthermore, similar neural induction defects were observed when RSV was applied to induced epiblast stem cells (EpiSCs) (Figures 2E–2J). These results demonstrate that SIRT1 activation specifically hinders the neural induction process.
RSV Inhibits the Neural Induction of mESCs in a SIRT1 Deacetylase Activity-Dependent Manner
To confirm the role of SIRT1 deacetylase activity in RSV treatment-induced neural induction defects, we first treated mESCs with RSV for 1.5 or 2.5 days under differentiation conditions and then collected the cells for western blotting. A remarkable decrease in the levels of acetylated H4K16 and H3K9, the two best-known SIRT1 histone targets, was observed after RSV treatment, whereas no obvious influences on other potential targets of RSV (e.g., GSK3β or ERK1/2 signaling) were detected (Figure 3A). We also immunoprecipitated SIRT1 from day-2.5 SFEBs in the absence or presence of RSV treatment, and examined SIRT1 deacetylase activity. The results showed that SIRT1 deacetylase activity was upregulated by more than 7-fold after RSV exposure, without obvious changes in SIRT1 protein levels (Figures 3B and S4A). Furthermore, as we expected, activating SIRT1 deacetylase using another potent activator, SRT1720, similarly inhibited the neural differentiation of 46C mESCs (Figures 3C, 3D, and S4B). These observations prove that SIRT1 deacetylase activation is sufficient to trigger neural induction defects.
Next, we used two efficient short hairpin RNAs (shRNAs) against the coding region of Sirt1 to knock down Sirt1, along with a control shRNA against Luciferase (shLuc) (Figures S4C and S4D). shLuc and shSirt1 mESCs were then subjected to neural differentiation for 5 days in the absence or presence of RSV treatment. Similar to wild-type mESCs, RSV-treated shLuc mESCs showed a lower efficiency of neural induction (Figures 3E–3H), whereas Sirt1 knockdown clearly potentiated the efficiency of neural induction in both the absence and presence of RSV treatment (Figures 3E–3H and S4E–S4G). Considering the pattern of decreased Sirt1 expression during normal neural differentiation (Figures S4H and S4I), we revealed that the downregulation of SIRT1 deacetylase activity is a prerequisite for the efficient conversion of pluripotent stem cells to a neural fate during gastrulation. Through CRISPR/Cas9-mediated homologous recombination, we further integrated CAG promoter-driven wild-type Sirt1 or a deacetylase-inactive Sirt1 mutant (Sirt1 H355A) into the Hprt locus for constitutive overexpression in mESCs (Cong et al., 2013, Koyama et al., 2006, Liu et al., 2016a). The overexpression efficiency was examined by qPCR and western blotting (Figures S4J and S4K). Overexpressing wild-type Sirt1 significantly retarded neural induction, whereas overexpressing the Sirt1 H355A mutant slightly potentiated rather than suppressed the efficiency of neural induction (Figures 3I–3L). Collectively our results indicate that RSV hinders the neural induction of mESCs in a SIRT1 deacetylase activity-dependent manner.
SIRT1 Directly Targets OCT6 and Then Activates Its Deacetylation/Ubiquitination/Degradation Cascade
Neural induction is tightly controlled by key neuroectodermal transcription factors, including Sox2, Otx2, Zic2, Pax6, and Oct6 (Acampora et al., 2013, Nagai et al., 2000, Zhang et al., 2010, Zhou et al., 2016, Zhu et al., 2014). To determine which transcription factors were responsible for the SIRT1 activation-induced neural induction defects, we overexpressed these transcription factors in RSV-treated mESCs, whereby only Oct6 overexpression improved the neural induction efficiency (Figures 4A–4C and S5A). Given that Oct6 initiates the neural induction program via direct activation of Zfp521, we found that overexpression of Zfp521 completely rescued the neural induction defects triggered by RSV treatment (Figures S5B–S5D), indicating that the Oct6/Zfp521 axis may be responsible for the SIRT1 activation-triggered neural induction defects. Interestingly, examining the mRNA and protein levels of Oct6 revealed that RSV markedly downregulated OCT6 protein expression, while the mRNA level remained unchanged (Figures 4D and 4E). Moreover, OCT6 enrichment in the enhancer regions of hallmark neural-lineage genes such as Zfp521 and Pax6 was also significantly decreased after RSV treatment (Figure 4F). These data suggested that SIRT1 activation might decrease OCT6 protein stability at the post-translational level, which thereby leads to the neural induction defects. To this end, we examined OCT6 expression levels in shSirt1 mESCs and found that Sirt1 knockdown upregulated OCT6 protein levels, but not Oct6 mRNA levels, in mESCs (Figures 4G and S5E) and rescued RSV-triggered OCT6 downregulation (Figures 4H and S5F). Furthermore, overexpression of wild-type Sirt1 but not the deacetylase-inactive mutant (Sirt1 H355A) decreased OCT6 protein expression (Figures 4I and S5G). All of these data suggest that the deacetylase activity of SIRT1 is negatively correlated with OCT6 protein stability.
Pretreatment with a potent proteasome inhibitor, MG132, stabilized OCT6 protein expression in the presence of RSV treatment (Figure 4J), indicating that the ubiquitin-proteasome pathway is involved in RSV-triggered OCT6 degradation. Immunoprecipitation using an acetylated lysine (Ac-Lys) antibody was then performed in day-2.5 SFEBs after pretreatment with MG132, for which the results showed that the acetylation of OCT6 was eliminated by RSV treatment (Figure 4K). In addition, RSV treatment induced robust ubiquitination of OCT6 (Figure 4L), consistent with the hypothesis that SIRT1 activation triggers the deacetylation/ubiquitination/degradation cascade of OCT6.
To verify the physical interaction between SIRT1 and OCT6, we pulled down endogenous SIRT1 in day-2.5 SFEBs and performed western blotting, which showed substantial amounts of OCT6 in the immunocomplexes (Figure 4M). Overexpression of Flag-tagged Sirt1 and hemagglutinin (HA)-tagged Oct6 in HEK 293FT cells also revealed strong binding of exogenous SIRT1 and OCT6 (Figure 4N). Moreover, SIRT1 H355A mutant showed an efficient interaction with OCT6 (Figure 4N), indicating that the deacetylase activity of SIRT1 is not required for the physical interaction between SIRT1 and OCT6, whereas the overexpression of wild-type SIRT1 resulted in significant deacetylation of OCT6 compared with the overexpression of the SIRT1 H355A mutant in HEK 293FT cells (Figure 4O). Furthermore, when the OCT6 K263&268Q mutant, which mimics constitutively acetylated OCT6 by mutating the two putative SIRT1-deacetylated lysine residues to glutamine, was overexpressed along with differentiation, RSV treatment failed to interfere with the neural induction of mESCs (Figures S5H–S5J). These data confirm that SIRT1 directly targets and deacetylates OCT6 to activate its ubiquitination/degradation cascade.
Oct6 Is Required for Neural Induction
A previous study established that mESCs in which Oct6 is knocked down tend to show decreased neural fate commitment (Zhu et al., 2014). To confirm that Oct6 indeed plays an essential role in neural induction, we generated Oct6−/− mESCs via CRISPR/Cas9-mediated open reading frame deletion (Liu et al., 2016b) (Figure S5K). Knockout efficiency was confirmed via genomic DNA PCR, western blotting, and qPCR (Figures S5K–S5N). After being subjected to neural differentiation, the Oct6−/− mESCs failed to efficiently convert to neuroectodermal cells, as demonstrated by much lower GFP induction and the reduced expression of neural-lineage-specific genes (Figures S5O–S5Q). In addition, reintroducing Oct6 into the Oct6−/− mESCs rescued the neural induction efficiency (Figures S5O–S5Q), confirming that the neural induction defects are correlated with a lack of OCT6 expression. As described above, Sirt1 knockdown in 46C mESCs potentiated neural induction. We next knocked down Sirt1 in Oct6−/− mESCs and found that Sirt1 knockdown failed to ameliorate the neural induction defects (Figure S5R). These results provide further evidence that OCT6 acts as a downstream target of SIRT1 and that the SIRT1/OCT6 axis determines neural induction from pluripotent stem cells.
The SIRT1/OCT6 Axis Is Responsible for Environmental Stress-Induced Neural Induction Defects
Epidemiological studies have implied that environmental stresses might serve as risk factors for NTDs (Salih et al., 2014). To examine whether environmental stresses indeed affect neural development, we treated mESCs with the reactive oxygen species inducer H2O2 or the DNA damage inducer hydroxyurea (HU), or starved cells via glucose withdrawal for 24 hr during the neural induction stage (approximate neural differentiation days 1.5–2.5). Remarkably, all of these environmental stresses significantly hindered neural induction and instead forced mESCs to adopt a non-neural fate or maintained the cells in a pluripotent stage under differentiation conditions (Figures 5A–5C and S6A). Considering that SIRT1 is usually activated by environmental stresses, we first analyzed SIRT1 deacetylase activity after stimulation to determine whether these environmental stresses interfered with neural induction by targeting the SIRT1/OCT6 axis. As with RSV treatment, SIRT1 deacetylase activity was significantly elevated under all the examined environmental stress conditions (Figures 5D and S6B). Western blotting showed that H2O2, HU, and glucose starvation also greatly downregulated OCT6 protein levels, but not its transcript (Figures 5E and S6C). Next, we studied the effects of H2O2 and HU exposure, as well as glucose starvation, in shSirt1 mESCs. In contrast to the shLuc mESCs, shSirt1 mESCs normally differentiated into neuroectodermal cells when challenged with these environmental stresses (Figures 5F, 5G, and S6D). Similarly, ectopic Oct6 expression also ameliorated the neural induction defects induced by these environmental stresses (Figures 5H, 5I, and S6E). Taken together, these results confirm that the SIRT1/OCT6 axis is responsible for the neural induction defects triggered by these environmental stresses.
Environmental Stresses Equally Target the SIRT1/OCT6 Axis and Retard Neural Induction in Human Embryonic Stem Cells
To determine whether environmental stresses also target the SIRT1/OCT6 axis and thereby cause neural induction defects in humans, we performed teratoma formation assays by injecting human ESCs (hESCs) into the immunodeficient mice in the absence or presence of daily RSV administration (50 mg/kg/day intragastrically). After 2 months, teratomas were harvested for histological and mRNA analysis. Similar to the data obtained from mouse teratomas, we found that neural-lineage induction was significantly hindered and that the populations of other layers as well as pluripotent cells were elevated after RSV administration (Figures S7A–S7C).
Next, we employed our well-established neural differentiation paradigm (Chi et al., 2016, Zhang and Zhang, 2010), with which hESCs can be efficiently converted into neuroectodermal cells uniformly expressing Sox1, Sox2, Nestin, and N-cadherin (Figures 6A and 6B, left panel). Supplementing the differentiation medium with RSV severely retarded the expression of all of these neural-lineage genes at both the protein and mRNA levels, with elevated expression of other non-neural-lineage genes (Figures 6A–6C and S7D). Consistently, RSV treatment markedly elevated SIRT1 deacetylase activity (Figures 6D and S7E) and decreased Oct6 expression at the protein level rather than the mRNA level (Figures 6E and S7F). All of these results suggest that the role of the SIRT1/OCT6 axis is potentially conserved between mice and humans. To this end, we knocked out Sirt1 in hESCs via the CRISPR/Cas9 system (Liu et al., 2016b) (Figure S7G) and subjected the cells to neural differentiation. Accordingly, we observed dramatically elevated OCT6 protein levels in Sirt1−/− hESCs during the early neural differentiation stage, when no OCT6 protein was detected in wild-type hESCs (Figure 6F). As neural differentiation proceeded, improved neural induction efficiency was observed in Sirt1−/− hESCs (Figure 6G). We next induced the neural induction of Sirt1−/− hESCs in the presence of RSV treatment. Accordingly, Sirt1−/− hESCs were resistant to the RSV-induced degradation of OCT6 protein and underwent normal neural induction under RSV exposure (Figures 6H and 6I). In addition, Sirt1 overexpression, H2O2 or HU treatment, and glucose starvation retarded the neural induction of hESCs in similar fashion (Figures 6J, 6K, S7H, and S7I). Collectively these observations suggest that the functional role of the SIRT1/OCT6 axis, which is responsible for environmental stress-triggered neural induction defects, is conserved between mice and humans.
The Functional Role of the SIRT1/OCT6 Axis in Environmental Stress-Induced NTDs during Early Embryogenesis
To confirm the physiological relevance of the SIRT1/OCT6 pathway in vivo, we first stained GD3.5 and GD6.5 embryos for SIRT1 and OCT6 and found that OCT6 protein levels were greatly upregulated at GD6.5 during normal gastrulation, which was accompanied by a significant decrease in SIRT1 expression (Figures 7A and 7B). In addition, Sirt1+/− embryos (Sirt1fl/fl mice crossed with EIIa-Cre mice) showed an obvious elevation in OCT6 protein levels (Figure 7C), indicating that SIRT1 negatively regulates OCT6 during normal embryonic development. To verify the role of SIRT1 in RSV-induced NTD-like phenotypes, we treated wild-type and Sirt1+/− embryos with RSV from GD3.5 to GD10.5. We found that 29.4% of wild-type embryos displayed NTD-like phenotypes, compared with only 5.8% of Sirt1+/− embryos (Figure 7D). Similarly, OCT6 protein levels were significantly decreased in wild-type embryos, whereas this decrease was obviously compromised in Sirt1+/− embryos at GD6.5 (Figure 7E).
Interestingly, brain-specific heterozygous Sirt1 knockout embryos (Sirt1fl/fl mice crossed with Nestin-Cre mice) showed a similar incidence of NTD-like phenotypes in wild-type embryos after maternal RSV administration (Figure 7D). Nestin is a neural-lineage-specific gene that is activated at approximately GD7.5. We then applied RSV starting at different gestational days until GD10.5. The results showed that RSV exposure from GD3.5, GD4.5, GD5.5, and GD6.5, but not afterward, efficiently induced NTD-like phenotypes; a single RSV administration at GD6.5 also induced NTD-like phenotypes (Figure 7F). Together, these results demonstrate that RSV/SIRT1/OCT6 pathway-triggered NTDs occur early on during neural induction, before the neural lineages have been specified. Indeed, we observed overlapping SIRT1 and OCT6 expression, the physical interaction between these two proteins, as well as the acetylation of OCT6 protein, at this developmental stage (Figures 7B, 7G, and S7J).
To recapitulate the functional role of the SIRT1/OCT6 pathway in environmental stress-induced NTDs, we employed radiation-induced NTDs as a pathophysiologically relevant in vivo model for NTDs. After 4 Gy radiation at GD5.5, 28.5% of wild-type embryos displayed NTD-like phenotypes, compared with only 6.8% of Sirt1+/− embryos (Figures 7H and S7K). Furthermore we found that after irradiation, OCT6 protein levels were significantly decreased in wild-type embryos, whereas this decrease was obviously compromised in Sirt1+/− embryos at GD6.5 (Figure 7I). Collectively, these data support the pathophysiological role of the SIRT1/OCT6 axis in environmental stress-induced NTDs (Figure 7J).
Discussion
In this study, we report an evolutionarily conserved SIRT1/OCT6 axis that is involved in abnormal neural induction in NTDs. RSV, oxidative stresses, starvation, and DNA damage inducers all activate SIRT1 deacetylase activity, which radically deacetylates OCT6 and triggers its ubiquitination/degradation cascade. Importantly, the dysregulation of the SIRT1/OCT6 axis will thereby induce NTD-like phenotypes in mice or hinder the neural induction of both hESCs and mESCs. Collectively, our data shed light on a pathophysiologically relevant role of the SIRT1/OCT6 axis in environmental stress-induced NTDs.
Annually, more than 300,000 neonates are born with NTDs worldwide. The risk of NTDs has long been proposed to be increased by environmental stresses, including maternal starvation, fever, and exposure to radiation or other teratogens, while the potential messenger between environmental stresses and NTDs remains unknown. SIRT1 has been reported to regulate the fate decision of neural stem/progenitor cells in response to environmental stimuli (Stein and Imai, 2014). However, NTDs arise when the process of neural tube formation is disrupted, which is an early developmental event. Therefore, whether SIRT1 is involved in environmental stress-induced NTDs remained to be explored. Our study strongly suggests that SIRT1 deacetylase activity is greatly modified by environmental stresses and is responsible for environmental stress-induced abnormal neural induction within the in vitro neural differentiation system of both hESCs and mESCs. Furthermore, in an in vivo radiation-induced NTD model, our results indicated that Sirt1 very likely translates environmental signals in developing embryos during early neural development and that SIRT1 activation critically contributes to environmental stress-induced NTDs.
Direct competition between lysine acetylation and ubiquitination has been proposed as a major mechanism regulating protein stability and has primarily been documented in cancer progression. p53, E2F1, SKP2, and MSH2 have been reported to be regulated by lysine acetylation and ubiquitination, which play important roles in DNA repair and tumorigenesis (Ito et al., 2002, Kontaki and Talianidis, 2010, Wang et al., 2012, Zhang et al., 2014). Recently, the functional relationship between acetylation and ubiquitination was assessed in a study of TAU-mediated neurodegeneration disorders (Min et al., 2015). However, little is known about the role of this post-translational interrelationship in early developmental events, because these events are mostly thought to be transcriptionally regulated. In the present study we discovered the inverse expression of SIRT1 and OCT6, and the active competition between OCT6 acetylation and ubiquitination during mouse gastrulation and the in vitro neural differentiation of both hESCs and mESCs. Notably, we identified a direct physical interaction between SIRT1 and OCT6 both in vivo and in vitro. Although the details regarding the specific OCT6 lysine residues that become acetylated or ubiquitinated remain to be further elucidated, the present study clearly demonstrates that active competition between OCT6 acetylation and ubiquitination is indispensable for normal neural induction.
Mammalian embryonic development is a highly coordinated set of processes involving dramatic but regular changes in the architecture of both the transcriptome and proteome. Previous reports have demonstrated that although the majority of human stage-specific gene expression modules are notably preserved in mouse embryos, the developmental specificity and timing dramatically differ between human and mouse (Xue et al., 2013). Species differences in embryonic development, especially neural induction (Zhang et al., 2010), make animal models suboptimal for studying the etiology and pathology of developmental disorders, including NTDs. In the present study, we clearly identified the direct activation of SIRT1 deacetylase activity upon environmental stress treatment and the resulting degradation of OCT6 protein via deacetylation/ubiquitination cascade during mouse neural differentiation and gastrulation. Importantly, we recapitulated the functional interplay between SIRT1 and OCT6 during human neural induction and found that it coincides exactly with the results from mice. Collectively, our data demonstrated that the developmental role of the SIRT1/OCT6 axis is evolutionarily conserved in both humans and mice; thus, a mouse model targeting the SIRT1/OCT6 axis will facilitate the study of abnormal neural induction in NTDs triggered by environmental stresses. Finally, the regulation of the SIRT1/OCT6 axis may serve as a target for preventing these devastating neurodevelopmental disorders.
Experimental Procedures
Animal Studies
All procedures involving animals were approved by the Laboratory Animal Care Committee of Tongji University under the Guide for the Care and Use of Laboratory Animals (NIH Guide). All mice were maintained in a pathogen-free environment throughout the experiments, and all efforts were made to minimizing the number of animals used and their suffering.
mESC Culture and Neural Differentiation
mESC lines 46C (kindly provided by Austin Smith's laboratory) and R1 (American Type Culture Collection) were maintained on irradiated mouse embryonic fibroblasts with leukemia inhibitory factor (1,000 U/mL, Millipore). For neural differentiation, mESCs were seeded at a density of (5 ± 1) × 104 cells/mL in GK8 medium, as described previously (Watanabe et al., 2005). All the cells were free of mycoplasma contamination.
Induced EpiSC Generation and Neural Differentiation
For generation of induced EpiSCs, mESCs were plated at a density of (5 ± 1) × 104 cells/mL in laminin-coated plates as described previously (Hayashi et al., 2011). For neural differentiation, induced EpiSC clones were dissociated and resuspended in GK8 medium.
hESC Culture and Neural Differentiation
The culture and neural differentiation of hESCs (H9, WA09, passages 25–45, WiCell Agreement No. 14-W0377) were performed as described previously (Zhang and Zhang, 2010).
mRNA Extraction and qPCR
Total RNAs were isolated from the desired cells using the TRIzol (Invitrogen), reverse transcribed into cDNA using SuperScript III First-Strand Synthesis System (Invitrogen), and subjected to qRT-PCR (Bio-Rad, CFX Connect Real-Time System) with the SYBR Premix Ex Taq (TakaRa). The primers used for qPCR are listed in Table S1.
Statistical Analysis
All statistical data are presented as the mean ± SEM of at least three independent experiments. Statistical significance was determined using unpaired two-tailed Student's t tests, except when specially noted otherwise.
Author Contributions
All authors discussed the experiments and contributed to the text of the manuscript. G.L. conducted most of the experiments and wrote a draft of the manuscript. Z.J. and R.W. contributed to plasmid construction and data collection. Z.J. and Y.H. contributed to the gene-editing studies. W.J., J.X., G.W., S.Z., Xin Zhang, D.F., and L.L. discussed the manuscript extensively and contributed to project conception and design. G.L., Xiaoqing Zhang, and J.K. conceived the project, analyzed the data, and wrote the manuscript.
Acknowledgments
The authors wish to thank Prof. Jun Xu for the transgenic mice. This work was supported by grants obtained from the Ministry of Science and Technology (grant numbers 2016YFA0101300, 2013CB967600, 2013CB967401, 2012CB966603), the National Natural Science Foundation of China (grant numbers 81530042, 31210103905, 31471250, 31371510, 31571519, 31571529, 31671533, 31571390, 31401257, 31401126, 31301213), the Ministry of Education Grant IRT_15R51, the Science and Technology Commission of Shanghai Municipality (grant numbers 15JC1403200, 15JC1400202), and the Fundamental Research Funds for the Central Universities (20002310002, 2000219136, 1507219042, 1500219106).
Published: April 20, 2017
Footnotes
Supplemental Information includes Supplemental Experimental Procedures, seven figures, and one table and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.2017.03.017.
Contributor Information
Xiaoqing Zhang, Email: xqzhang@tongji.edu.cn.
Jiuhong Kang, Email: jhkang@tongji.edu.cn.
Supplemental Information
References
- Acampora D., Di Giovannantonio L.G., Simeone A. Otx2 is an intrinsic determinant of the embryonic stem cell state and is required for transition to a stable epiblast stem cell condition. Development. 2013;140:43–55. doi: 10.1242/dev.085290. [DOI] [PubMed] [Google Scholar]
- Brunet A., Sweeney L.B., Sturgill J.F., Chua K.F., Greer P.L., Lin Y., Tran H., Ross S.E., Mostoslavsky R., Cohen H.Y. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science. 2004;303:2011–2015. doi: 10.1126/science.1094637. [DOI] [PubMed] [Google Scholar]
- Chang C., Su H., Zhang D., Wang Y., Shen Q., Liu B., Huang R., Zhou T., Peng C., Wong C.C. AMPK-dependent phosphorylation of GAPDH triggers sirt1 activation and is necessary for autophagy upon glucose starvation. Mol. Cell. 2015;60:930–940. doi: 10.1016/j.molcel.2015.10.037. [DOI] [PubMed] [Google Scholar]
- Chi L., Fan B., Zhang K., Du Y., Liu Z., Fang Y., Chen Z., Ren X., Xu X., Jiang C. Targeted differentiation of regional ventral neuroprogenitors and related neuronal subtypes from human pluripotent stem cells. Stem Cell Rep. 2016;7:941–954. doi: 10.1016/j.stemcr.2016.09.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cho A., Tang Y., Davila J., Deng S., Chen L., Miller E., Wernig M., Graef I.A. Calcineurin signaling regulates neural induction through antagonizing the BMP pathway. Neuron. 2014;82:109–124. doi: 10.1016/j.neuron.2014.02.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cong L., Ran F.A., Cox D., Lin S., Barretto R., Habib N., Hsu P.D., Wu X., Jiang W., Marraffini L.A. Multiplex genome engineering using CRISPR/Cas systems. Science. 2013;339:819–823. doi: 10.1126/science.1231143. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Copp A.J., Greene N.D., Murdoch J.N. The genetic basis of mammalian neurulation. Nat. Rev. Genet. 2003;4:784–793. doi: 10.1038/nrg1181. [DOI] [PubMed] [Google Scholar]
- Fairbridge N.A., Dawe C.E., Niri F.H., Kooistra M.K., King-Jones K., McDermid H.E. Cecr2 mutations causing exencephaly trigger misregulation of mesenchymal/ectodermal transcription factors. Birth Defects Res. A Clin. Mol. Teratol. 2010;88:619–625. doi: 10.1002/bdra.20695. [DOI] [PubMed] [Google Scholar]
- Han M.K., Song E.K., Guo Y., Ou X., Mantel C., Broxmeyer H.E. SIRT1 regulates apoptosis and Nanog expression in mouse embryonic stem cells by controlling p53 subcellular localization. Cell Stem Cell. 2008;2:241–251. doi: 10.1016/j.stem.2008.01.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Harris M.J., Juriloff D.M. An update to the list of mouse mutants with neural tube closure defects and advances toward a complete genetic perspective of neural tube closure. Birth Defects Res. A Clin. Mol. Teratol. 2010;88:653–669. doi: 10.1002/bdra.20676. [DOI] [PubMed] [Google Scholar]
- Hayashi K., Ohta H., Kurimoto K., Aramaki S., Saitou M. Reconstitution of the mouse germ cell specification pathway in culture by pluripotent stem cells. Cell. 2011;146:519–532. doi: 10.1016/j.cell.2011.06.052. [DOI] [PubMed] [Google Scholar]
- Herrera-Araujo D. Folic acid advisories: a public health challenge? Health Econ. 2016;25:1104–1122. doi: 10.1002/hec.3362. [DOI] [PubMed] [Google Scholar]
- Hsieh C.L., Chen K.C., Ding C.Y., Tsai W.J., Wu J.F., Peng C.C. Valproic acid substantially downregulated genes folr1, IGF2R, RGS2, COL6A3, EDNRB, KLF6, and pax-3, N-acetylcysteine alleviated most of the induced gene alterations in chicken embryo model. Rom. J. Morphol. Embryol. 2013;54:993–1004. [PubMed] [Google Scholar]
- Ito A., Kawaguchi Y., Lai C.H., Kovacs J.J., Higashimoto Y., Appella E., Yao T.P. MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation. EMBO J. 2002;21:6236–6245. doi: 10.1093/emboj/cdf616. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kamiya D., Banno S., Sasai N., Ohgushi M., Inomata H., Watanabe K., Kawada M., Yakura R., Kiyonari H., Nakao K. Intrinsic transition of embryonic stem-cell differentiation into neural progenitors. Nature. 2011;470:503–509. doi: 10.1038/nature09726. [DOI] [PubMed] [Google Scholar]
- Kang H., Jung J.W., Kim M.K., Chung J.H. CK2 is the regulator of SIRT1 substrate-binding affinity, deacetylase activity and cellular response to DNA-damage. PLoS One. 2009;4:e6611. doi: 10.1371/journal.pone.0006611. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kontaki H., Talianidis I. Lysine methylation regulates E2F1-induced cell death. Mol. Cell. 2010;39:152–160. doi: 10.1016/j.molcel.2010.06.006. [DOI] [PubMed] [Google Scholar]
- Koyama Y., Banzai T., Sonezaki S., Kusano K. Stable expression of a heterogeneous gene introduced via gene targeting into the HPRT locus of human fibrosarcoma cells. Biotechnol. Bioeng. 2006;95:1052–1060. doi: 10.1002/bit.21058. [DOI] [PubMed] [Google Scholar]
- Lee I.H., Cao L., Mostoslavsky R., Lombard D.B., Liu J., Bruns N.E., Tsokos M., Alt F.W., Finkel T. A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy. Proc. Natl. Acad. Sci. USA. 2008;105:3374–3379. doi: 10.1073/pnas.0712145105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Liu L., Liu X., Ren X., Tian Y., Chen Z., Xu X., Du Y., Jiang C., Fang Y., Liu Z. Smad2 and Smad3 have differential sensitivity in relaying TGFbeta signaling and inversely regulate early lineage specification. Sci. Rep. 2016;6:21602. doi: 10.1038/srep21602. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Liu Z., Hui Y., Shi L., Chen Z., Xu X., Chi L., Fan B., Fang Y., Liu Y., Ma L. Efficient CRISPR/Cas9-mediated versatile, predictable, and donor-free gene knockout in human pluripotent stem cells. Stem Cell Rep. 2016;7:496–507. doi: 10.1016/j.stemcr.2016.07.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Luo J., Nikolaev A.Y., Imai S., Chen D., Su F., Shiloh A., Guarente L., Gu W. Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell. 2001;107:137–148. doi: 10.1016/s0092-8674(01)00524-4. [DOI] [PubMed] [Google Scholar]
- Min S.W., Chen X., Tracy T.E., Li Y., Zhou Y., Wang C., Shirakawa K., Minami S.S., Defensor E., Mok S.A. Critical role of acetylation in tau-mediated neurodegeneration and cognitive deficits. Nat. Med. 2015;21:1154–1162. doi: 10.1038/nm.3951. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nagai T., Aruga J., Minowa O., Sugimoto T., Ohno Y., Noda T., Mikoshiba K. Zic2 regulates the kinetics of neurulation. Proc. Natl. Acad. Sci. USA. 2000;97:1618–1623. doi: 10.1073/pnas.97.4.1618. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pallas M., Casadesus G., Smith M.A., Coto-Montes A., Pelegri C., Vilaplana J., Camins A. Resveratrol and neurodegenerative diseases: activation of SIRT1 as the potential pathway towards neuroprotection. Curr. Neurovasc. Res. 2009;6:70–81. doi: 10.2174/156720209787466019. [DOI] [PubMed] [Google Scholar]
- Prozorovski T., Schulze-Topphoff U., Glumm R., Baumgart J., Schroter F., Ninnemann O., Siegert E., Bendix I., Brustle O., Nitsch R. Sirt1 contributes critically to the redox-dependent fate of neural progenitors. Nat. Cell Biol. 2008;10:385–394. doi: 10.1038/ncb1700. [DOI] [PubMed] [Google Scholar]
- Salih M.A., Murshid W.R., Seidahmed M.Z. Epidemiology, prenatal management, and prevention of neural tube defects. Saudi Med. J. 2014;35(Suppl 1):S15–S28. [PMC free article] [PubMed] [Google Scholar]
- Stavridis M.P., Lunn J.S., Collins B.J., Storey K.G. A discrete period of FGF-induced Erk1/2 signalling is required for vertebrate neural specification. Development. 2007;134:2889–2894. doi: 10.1242/dev.02858. [DOI] [PubMed] [Google Scholar]
- Stein L.R., Imai S. Specific ablation of Nampt in adult neural stem cells recapitulates their functional defects during aging. EMBO J. 2014;33:1321–1340. doi: 10.1002/embj.201386917. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tam P.P., Zhou S.X. The allocation of epiblast cells to ectodermal and germ-line lineages is influenced by the position of the cells in the gastrulating mouse embryo. Dev. Biol. 1996;178:124–132. doi: 10.1006/dbio.1996.0203. [DOI] [PubMed] [Google Scholar]
- Wang Z., Inuzuka H., Zhong J., Liu P., Sarkar F.H., Sun Y., Wei W. Identification of acetylation-dependent regulatory mechanisms that govern the oncogenic functions of Skp2. Oncotarget. 2012;3:1294–1300. doi: 10.18632/oncotarget.740. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Watanabe K., Kamiya D., Nishiyama A., Katayama T., Nozaki S., Kawasaki H., Watanabe Y., Mizuseki K., Sasai Y. Directed differentiation of telencephalic precursors from embryonic stem cells. Nat. Neurosci. 2005;8:288–296. doi: 10.1038/nn1402. [DOI] [PubMed] [Google Scholar]
- Wood J.G., Rogina B., Lavu S., Howitz K., Helfand S.L., Tatar M., Sinclair D. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature. 2004;430:686–689. doi: 10.1038/nature02789. [DOI] [PubMed] [Google Scholar]
- Xue Z., Huang K., Cai C., Cai L., Jiang C.Y., Feng Y., Liu Z., Zeng Q., Cheng L., Sun Y.E. Genetic programs in human and mouse early embryos revealed by single-cell RNA sequencing. Nature. 2013;500:593–597. doi: 10.1038/nature12364. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ying Q.L., Nichols J., Chambers I., Smith A. BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell. 2003;115:281–292. doi: 10.1016/s0092-8674(03)00847-x. [DOI] [PubMed] [Google Scholar]
- Ying Q.L., Stavridis M., Griffiths D., Li M., Smith A. Conversion of embryonic stem cells into neuroectodermal precursors in adherent monoculture. Nat. Biotechnol. 2003;21:183–186. doi: 10.1038/nbt780. [DOI] [PubMed] [Google Scholar]
- Yoo Y.D., Huang C.T., Zhang X., Lavaute T.M., Zhang S.C. Fibroblast growth factor regulates human neuroectoderm specification through ERK1/2-PARP-1 pathway. Stem Cells. 2011;29:1975–1982. doi: 10.1002/stem.758. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhang X.Q., Zhang S.C. Differentiation of neural precursors and dopaminergic neurons from human embryonic stem cells. Methods Mol. Biol. 2010;584:355–366. doi: 10.1007/978-1-60761-369-5_19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhang X., Huang C.T., Chen J., Pankratz M.T., Xi J., Li J., Yang Y., Lavaute T.M., Li X.J., Ayala M. Pax6 is a human neuroectoderm cell fate determinant. Cell Stem Cell. 2010;7:90–100. doi: 10.1016/j.stem.2010.04.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhang M., Xiang S., Joo H.Y., Wang L., Williams K.A., Liu W., Hu C., Tong D., Haakenson J., Wang C. HDAC6 deacetylates and ubiquitinates MSH2 to maintain proper levels of MutSalpha. Mol. Cell. 2014;55:31–46. doi: 10.1016/j.molcel.2014.04.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhou C., Yang X., Sun Y., Yu H., Zhang Y., Jin Y. Comprehensive profiling reveals mechanisms of SOX2-mediated cell fate specification in human ESCs and NPCs. Cell Res. 2016;26:171–189. doi: 10.1038/cr.2016.15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhu Q., Song L., Peng G., Sun N., Chen J., Zhang T., Sheng N., Tang W., Qian C., Qiao Y. The transcription factor Pou3f1 promotes neural fate commitment via activation of neural lineage genes and inhibition of external signaling pathways. Elife. 2014;3:e02224. doi: 10.7554/eLife.02224. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zwart R., Broos L., Grosveld G., Meijer D. The restricted expression pattern of the POU factor Oct-6 during early development of the mouse nervous system. Mech. Dev. 1996;54:185–194. doi: 10.1016/0925-4773(95)00472-6. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.